A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion by Sharma, Jyoti, Du, Ming, Wong, Eric, Mutyam, Venkateshwar, Li, Yao, Chen, Jianguo, Wangen, Jamie, Thrasher, Kari, Fu, Lianwu, Peng, Ning, Tang, Liping, Liu, Kaimao, Mathew, Bini, Bostwick, Robert J., Augelli-Szafran, Corinne E., Bihler, Hermann, Liang, Feng, Mahiou, Jerome, Saltz, Josef, Rab, Andras, Hong, Jeong, Sorscher, Eric J., Mendenhall, Eric M., Coppola, Candice J., Keeling, Kim M., Green, Rachel, Mense, Martin, Suto, Mark J., Rowe, Steven M., Bedwell, David M.

Get full text

High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations by Liang, Feng, Shang, Haibo, Jordan, Nikole J., Wong, Eric, Mercadante, Dayna, Saltz, Josef, Mahiou, Jerome, Bihler, Hermann J., Mense, Martin

Get full text

Primary tumor location as a prognostic factor in metastatic colorectal cancer by Loupakis, Fotios, Yang, Dongyun, Yau, Linda, Feng, Shibao, Cremolini, Chiara, Zhang, Wu, Maus, Martin K H, Antoniotti, Carlotta, Langer, Christiane, Scherer, Stefan J, Müller, Thomas, Hurwitz, Herbert I, Saltz, Leonard, Falcone, Alfredo, Lenz, Heinz-Josef

Get full text

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803 by Niedzwiecki, Donna, Hasson, Rian M., Lenz, Heinz‐Josef, Ye, Cynthia, Redston, Mark, Ogino, Shuji, Fuchs, Charles S., Compton, Carolyn C., Mayer, Robert J., Goldberg, Richard M., Colacchio, Thomas A., Saltz, Leonard B., Warren, Robert S., Bertagnolli, Monica M.

Get full text

Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database by Margalit, Ofer, Harmsen, William S., Shacham-Shmueli, Einat, Voss, Molly M., Boursi, Ben, Wagner, Anna D., Cohen, Romain, Olswold, Curtis L., Saltz, Leonard B., Goldstein, Daniel A., Hurwitz, Herbert, Tebbutt, Niall C., Kabbinavar, Fairooz F., Adams, Richard A., Chibaudel, Benoist, Grothey, Axel, Yoshino, Takayuki, Zalcberg, John, de Gramont, Aimery, Shi, Qian, Lenz, Heinz-Josef

Get full text

Corrigendum to “Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database” Eur J... by Margalit, Ofer, Harmsen, William S., Shacham-Shmueli, Einat, Voss, Molly M., Boursi, Ben, Wagner, Anna D., Cohen, Romain, Olswold, Curtis L., Saltz, Leonard B., Goldstein, Daniel A., Hurwitz, Herbert, Tebbutt, Niall C., Kabbinavar, Fairooz F., Adams, Richard A., Chibaudel, Benoist, Grothey, Axel, Yoshino, Takayuki, Zalcberg, John, de Gramont, Aimery, Shi, Qian, Lenz, Heinz-Josef

Get full text

Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer by Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef

Get full text

First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors by Keedy, Vicki L., Lenz, Heinz-Josef, Saltz, Leonard, Whisenant, Jennifer G., Berlin, Jordan D., Camacho, Luis H.

Get full text

Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study) by WU ZHANG, AZUMA, Mizutomo, HOLLYWOOD, Ellen, DANENBERG, Kathleen D, SALTZ, Leonard, LENZ, Heinz-Josef, LURJE, Georg, GORDON, Michael A, DONGYUN YANG, POHL, Alexandra, YAN NING, BOHANES, Pierre, GERGER, Armin, WINDER, Thomas

Get full text